CHA
LLY icon

Carmichael Hill & Associates’s Eli Lilly LLY Stock Holding History

Carmichael Hill & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– – – 83

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Carmichael Hill & Associates's LLY Position: Q3 2024 in Review

Carmichael Hill & Associates increased its Eli Lilly (LLY) stake by 0.2% in Q3 2024, buying an estimated $5.39K and bringing the position to 3,013 shares worth $2.67M. The position accounts for 0.95% of the portfolio, ranked #25.

Carmichael Hill & Associates first reported a position in LLY in Q4 2017 and has held it in 28 quarters since. The position peaked at $2.72M in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Carmichael Hill & Associates held 3,013 shares of Eli Lilly worth $2.67M as of Q3 2024.
  • Carmichael Hill & Associates bought 6 Eli Lilly shares in Q3 2024, an estimated $5.39K.
  • Eli Lilly made up 0.95% of Carmichael Hill & Associates's portfolio in Q3 2024, its #25 holding.
  • Carmichael Hill & Associates first reported a position in Eli Lilly in Q4 2017 and has held it in 28 quarters since.
  • Carmichael Hill & Associates's Eli Lilly position peaked at $2.72M in Q2 2024.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.